Skip to content

Clinical trials

Endometrial Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: Russia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20092
20101
20122
20131
20141
20171
20181
20191
20203
20212
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting5
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Merck Sharp & Dohme LLC3
Eisai Inc.2
AEterna Zentaris1
Byondis B.V.1
Checkpoint Therapeutics, Inc.1
Ipsen1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Moscow City Oncology Hospital No. 621
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms18
Neoplasms3
Uterine Neoplasms3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Ovarian Neoplasms2
Biliary Tract Neoplasms1
Carcinoma1
Carcinoma, Merkel Cell1
Carcinoma, Renal Cell1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.